Miquel joined TechLife Capital as an Analyst in January 2026.

​

Prior to joining TechLife Capital, Miquel worked at Lauxera Capital Partners, where he supported investments in pharma services, healthcare software, and life sciences across Europe and the US.

​

He began his career in healthcare private equity at ARCHIMED, where he worked on deal execution, including the acquisition of a French medtech company, as well as deal sourcing and portfolio management.​​

 

​Miquel holds a Master of Engineering degree in Bioengineering from The University of Sheffield.